Announcements Trials

Browse Landscape

Phase

Phase 1 3 Phase 2 2 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 27 Neoplasms 22 Breast Neoplasms 20 Neoplasm Metastasis 18 Colorectal Neoplasms 16 Stomach Neoplasms 15 Recurrence 15 Prostatic Neoplasms 15 Carcinoma, Hepatocellular 12 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Head and Neck Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 10 Lung Neoplasms 10 Myasthenia Gravis 9 Melanoma 9 Leukemia, Myeloid, Acute 9 Urinary Bladder Neoplasms 8 Lymphoma, Large B-Cell, Diffuse 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Liver Neoplasms 6 Cholangiocarcinoma 6 Carcinoma, Transitional Cell 6 Triple Negative Breast Neoplasms 5 Small Cell Lung Carcinoma 5 Lymphoma, Follicular 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × INDUSTRY × SCLC × Clear all

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡